Edward J. McGowan - 10 Mar 2026 Form 4 Insider Report for AKAMAI TECHNOLOGIES INC (AKAM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
10 Mar 2026, 16:13:29 UTC
Prior SEC filing
06 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas M. Lair, as power of attorney

Key filing fact

Edward J. McGowan filed Form 4 for AKAMAI TECHNOLOGIES INC (AKAM) on 10 Mar 2026.

Key facts

  • This page summarizes Edward J. McGowan's Form 4 filing for AKAMAI TECHNOLOGIES INC (AKAM).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Mar 2026, 16:13.

Change

  • Previous filing in this sequence was filed on 06 Mar 2026.
  • Current net transaction value: -$1,390,925.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001767894 Primary reporting owner

McGowan Edward J

Relationship
Chief Financial Officer
Address
C/O AKAMAI TECHNOLOGIES, INC., 145 BROADWAY, CAMBRIDGE
Signature
/s/ Thomas M. Lair, as power of attorney
Signature date
10 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AKAM transaction

Common Stock

Sale

Transaction value
$982,821
Shares
-9,734
Change %
-19%
Price
$100.97
Shares after
42,795
Date
10 Mar 2026
Ownership
Direct
Footnotes
F1, F2, F3
AKAM transaction

Common Stock

Sale

Transaction value
$408,104
Shares
-4,011
Change %
-9.4%
Price
$101.75
Shares after
38,784
Date
10 Mar 2026
Ownership
Direct
Footnotes
F1, F3, F4
AKAM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
125
Date
10 Mar 2026
Ownership
By 401(k) Plan
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.485 to $101.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.52 to $101.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

As of March 9, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .